/
A Phase 23 Clinical Study of Nusinersen in Infants Children and Adult A Phase 23 Clinical Study of Nusinersen in Infants Children and Adult

A Phase 23 Clinical Study of Nusinersen in Infants Children and Adult - PowerPoint Presentation

eliza
eliza . @eliza
Follow
342 views
Uploaded On

A Phase 23 Clinical Study of Nusinersen in Infants Children and Adult - PPT Presentation

Biogen24973Spinal muscular atrophy SMA is a genetic disease that causes severe muscle weakness loss of movement and difficulty breathing While there are now treatment options there is still no cure a ID: 890301

sma study clinical gene study sma gene clinical genetic participation participant test biogen 24973 medical process mutated smn1 visits

Share:

Link:

Embed:

Download Presentation from below link

Download The PPT/PDF document "A Phase 23 Clinical Study of Nusinersen ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript
A Phase 23 Clinical Study of Nusinersen in Infants Children and Adult - pdf download. Biogen24973Spinal muscular atrophy SMA is a genetic disease that causes severe muscle weakness loss of movement and difficulty breathing While there are now treatment options there is still no cure a ID: 890301.. https://www.docslides.com/slides/a-phase-23-clinical-study-of-nusinersen-in-infants-children-and-adult.html